Report Detail

Pharma & Healthcare COVID-19 Impact on Global Regenerative Medicine Products, Market Insights and Forecast to 2026

  • RnM4081747
  • |
  • 29 June, 2020
  • |
  • Global
  • |
  • 147 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Regenerative Medicine Products market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Regenerative Medicine Products market is segmented into
Cell Therapy
Tissue Engineering
Biomaterial
Others

Segment by Application, the Regenerative Medicine Products market is segmented into
Dermatology
Cardiovascular
CNS
Orthopedic
Others

Regional and Country-level Analysis
The Regenerative Medicine Products market is analysed and market size information is provided by regions (countries).
The key regions covered in the Regenerative Medicine Products market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Regenerative Medicine Products Market Share Analysis
Regenerative Medicine Products market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Regenerative Medicine Products business, the date to enter into the Regenerative Medicine Products market, Regenerative Medicine Products product introduction, recent developments, etc.
The major vendors covered:
Acelity
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori Therapeutics
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologes
Bellicum Pharmaceuticals


1 Study Coverage

  • 1.1 Regenerative Medicine Products Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Regenerative Medicine Products Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Regenerative Medicine Products Market Size Growth Rate by Type
    • 1.4.2 Cell Therapy
    • 1.4.3 Tissue Engineering
    • 1.4.4 Biomaterial
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global Regenerative Medicine Products Market Size Growth Rate by Application
    • 1.5.2 Dermatology
    • 1.5.3 Cardiovascular
    • 1.5.4 CNS
    • 1.5.5 Orthopedic
    • 1.5.6 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Regenerative Medicine Products Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Regenerative Medicine Products Industry
      • 1.6.1.1 Regenerative Medicine Products Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Regenerative Medicine Products Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Regenerative Medicine Products Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Regenerative Medicine Products Market Size Estimates and Forecasts
    • 2.1.1 Global Regenerative Medicine Products Revenue 2015-2026
    • 2.1.2 Global Regenerative Medicine Products Sales 2015-2026
  • 2.2 Regenerative Medicine Products Market Size by Region: 2020 Versus 2026
    • 2.2.1 Global Regenerative Medicine Products Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Regenerative Medicine Products Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Regenerative Medicine Products Competitor Landscape by Players

  • 3.1 Regenerative Medicine Products Sales by Manufacturers
    • 3.1.1 Regenerative Medicine Products Sales by Manufacturers (2015-2020)
    • 3.1.2 Regenerative Medicine Products Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Regenerative Medicine Products Revenue by Manufacturers
    • 3.2.1 Regenerative Medicine Products Revenue by Manufacturers (2015-2020)
    • 3.2.2 Regenerative Medicine Products Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Regenerative Medicine Products Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Regenerative Medicine Products Revenue in 2019
    • 3.2.5 Global Regenerative Medicine Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Regenerative Medicine Products Price by Manufacturers
  • 3.4 Regenerative Medicine Products Manufacturing Base Distribution, Product Types
    • 3.4.1 Regenerative Medicine Products Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Regenerative Medicine Products Product Type
    • 3.4.3 Date of International Manufacturers Enter into Regenerative Medicine Products Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Regenerative Medicine Products Market Size by Type (2015-2020)
    • 4.1.1 Global Regenerative Medicine Products Sales by Type (2015-2020)
    • 4.1.2 Global Regenerative Medicine Products Revenue by Type (2015-2020)
    • 4.1.3 Regenerative Medicine Products Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Regenerative Medicine Products Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Regenerative Medicine Products Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Regenerative Medicine Products Revenue Forecast by Type (2021-2026)
    • 4.2.3 Regenerative Medicine Products Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Regenerative Medicine Products Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

  • 5.1 Global Regenerative Medicine Products Market Size by Application (2015-2020)
    • 5.1.1 Global Regenerative Medicine Products Sales by Application (2015-2020)
    • 5.1.2 Global Regenerative Medicine Products Revenue by Application (2015-2020)
    • 5.1.3 Regenerative Medicine Products Price by Application (2015-2020)
  • 5.2 Regenerative Medicine Products Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Regenerative Medicine Products Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Regenerative Medicine Products Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Regenerative Medicine Products Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Regenerative Medicine Products by Country
    • 6.1.1 North America Regenerative Medicine Products Sales by Country
    • 6.1.2 North America Regenerative Medicine Products Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Regenerative Medicine Products Market Facts & Figures by Type
  • 6.3 North America Regenerative Medicine Products Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Regenerative Medicine Products by Country
    • 7.1.1 Europe Regenerative Medicine Products Sales by Country
    • 7.1.2 Europe Regenerative Medicine Products Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Regenerative Medicine Products Market Facts & Figures by Type
  • 7.3 Europe Regenerative Medicine Products Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Regenerative Medicine Products by Region
    • 8.1.1 Asia Pacific Regenerative Medicine Products Sales by Region
    • 8.1.2 Asia Pacific Regenerative Medicine Products Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Regenerative Medicine Products Market Facts & Figures by Type
  • 8.3 Asia Pacific Regenerative Medicine Products Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Regenerative Medicine Products by Country
    • 9.1.1 Latin America Regenerative Medicine Products Sales by Country
    • 9.1.2 Latin America Regenerative Medicine Products Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Regenerative Medicine Products Market Facts & Figures by Type
  • 9.3 Central & South America Regenerative Medicine Products Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Regenerative Medicine Products by Country
    • 10.1.1 Middle East and Africa Regenerative Medicine Products Sales by Country
    • 10.1.2 Middle East and Africa Regenerative Medicine Products Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Regenerative Medicine Products Market Facts & Figures by Type
  • 10.3 Middle East and Africa Regenerative Medicine Products Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Acelity
    • 11.1.1 Acelity Corporation Information
    • 11.1.2 Acelity Description, Business Overview and Total Revenue
    • 11.1.3 Acelity Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Acelity Regenerative Medicine Products Products Offered
    • 11.1.5 Acelity Recent Development
  • 11.2 DePuy Synthes
    • 11.2.1 DePuy Synthes Corporation Information
    • 11.2.2 DePuy Synthes Description, Business Overview and Total Revenue
    • 11.2.3 DePuy Synthes Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 DePuy Synthes Regenerative Medicine Products Products Offered
    • 11.2.5 DePuy Synthes Recent Development
  • 11.3 Medtronic
    • 11.3.1 Medtronic Corporation Information
    • 11.3.2 Medtronic Description, Business Overview and Total Revenue
    • 11.3.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Medtronic Regenerative Medicine Products Products Offered
    • 11.3.5 Medtronic Recent Development
  • 11.4 ZimmerBiomet
    • 11.4.1 ZimmerBiomet Corporation Information
    • 11.4.2 ZimmerBiomet Description, Business Overview and Total Revenue
    • 11.4.3 ZimmerBiomet Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 ZimmerBiomet Regenerative Medicine Products Products Offered
    • 11.4.5 ZimmerBiomet Recent Development
  • 11.5 Stryker
    • 11.5.1 Stryker Corporation Information
    • 11.5.2 Stryker Description, Business Overview and Total Revenue
    • 11.5.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Stryker Regenerative Medicine Products Products Offered
    • 11.5.5 Stryker Recent Development
  • 11.6 MiMedx Group
    • 11.6.1 MiMedx Group Corporation Information
    • 11.6.2 MiMedx Group Description, Business Overview and Total Revenue
    • 11.6.3 MiMedx Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 MiMedx Group Regenerative Medicine Products Products Offered
    • 11.6.5 MiMedx Group Recent Development
  • 11.7 Organogenesis
    • 11.7.1 Organogenesis Corporation Information
    • 11.7.2 Organogenesis Description, Business Overview and Total Revenue
    • 11.7.3 Organogenesis Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Organogenesis Regenerative Medicine Products Products Offered
    • 11.7.5 Organogenesis Recent Development
  • 11.8 UniQure
    • 11.8.1 UniQure Corporation Information
    • 11.8.2 UniQure Description, Business Overview and Total Revenue
    • 11.8.3 UniQure Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 UniQure Regenerative Medicine Products Products Offered
    • 11.8.5 UniQure Recent Development
  • 11.9 Cellular Dynamics International
    • 11.9.1 Cellular Dynamics International Corporation Information
    • 11.9.2 Cellular Dynamics International Description, Business Overview and Total Revenue
    • 11.9.3 Cellular Dynamics International Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Cellular Dynamics International Regenerative Medicine Products Products Offered
    • 11.9.5 Cellular Dynamics International Recent Development
  • 11.10 Osiris Therapeutics
    • 11.10.1 Osiris Therapeutics Corporation Information
    • 11.10.2 Osiris Therapeutics Description, Business Overview and Total Revenue
    • 11.10.3 Osiris Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Osiris Therapeutics Regenerative Medicine Products Products Offered
    • 11.10.5 Osiris Therapeutics Recent Development
  • 11.1 Acelity
    • 11.1.1 Acelity Corporation Information
    • 11.1.2 Acelity Description, Business Overview and Total Revenue
    • 11.1.3 Acelity Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Acelity Regenerative Medicine Products Products Offered
    • 11.1.5 Acelity Recent Development
  • 11.12 Gamida Cell
    • 11.12.1 Gamida Cell Corporation Information
    • 11.12.2 Gamida Cell Description, Business Overview and Total Revenue
    • 11.12.3 Gamida Cell Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Gamida Cell Products Offered
    • 11.12.5 Gamida Cell Recent Development
  • 11.13 Golden Meditech
    • 11.13.1 Golden Meditech Corporation Information
    • 11.13.2 Golden Meditech Description, Business Overview and Total Revenue
    • 11.13.3 Golden Meditech Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Golden Meditech Products Offered
    • 11.13.5 Golden Meditech Recent Development
  • 11.14 Cytori Therapeutics
    • 11.14.1 Cytori Therapeutics Corporation Information
    • 11.14.2 Cytori Therapeutics Description, Business Overview and Total Revenue
    • 11.14.3 Cytori Therapeutics Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Cytori Therapeutics Products Offered
    • 11.14.5 Cytori Therapeutics Recent Development
  • 11.15 Celgene
    • 11.15.1 Celgene Corporation Information
    • 11.15.2 Celgene Description, Business Overview and Total Revenue
    • 11.15.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Celgene Products Offered
    • 11.15.5 Celgene Recent Development
  • 11.16 Vericel Corporation
    • 11.16.1 Vericel Corporation Corporation Information
    • 11.16.2 Vericel Corporation Description, Business Overview and Total Revenue
    • 11.16.3 Vericel Corporation Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Vericel Corporation Products Offered
    • 11.16.5 Vericel Corporation Recent Development
  • 11.17 Guanhao Biotech
    • 11.17.1 Guanhao Biotech Corporation Information
    • 11.17.2 Guanhao Biotech Description, Business Overview and Total Revenue
    • 11.17.3 Guanhao Biotech Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Guanhao Biotech Products Offered
    • 11.17.5 Guanhao Biotech Recent Development
  • 11.18 Mesoblast
    • 11.18.1 Mesoblast Corporation Information
    • 11.18.2 Mesoblast Description, Business Overview and Total Revenue
    • 11.18.3 Mesoblast Sales, Revenue and Gross Margin (2015-2020)
    • 11.18.4 Mesoblast Products Offered
    • 11.18.5 Mesoblast Recent Development
  • 11.19 Stemcell Technologes
    • 11.19.1 Stemcell Technologes Corporation Information
    • 11.19.2 Stemcell Technologes Description, Business Overview and Total Revenue
    • 11.19.3 Stemcell Technologes Sales, Revenue and Gross Margin (2015-2020)
    • 11.19.4 Stemcell Technologes Products Offered
    • 11.19.5 Stemcell Technologes Recent Development
  • 11.20 Bellicum Pharmaceuticals
    • 11.20.1 Bellicum Pharmaceuticals Corporation Information
    • 11.20.2 Bellicum Pharmaceuticals Description, Business Overview and Total Revenue
    • 11.20.3 Bellicum Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
    • 11.20.4 Bellicum Pharmaceuticals Products Offered
    • 11.20.5 Bellicum Pharmaceuticals Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Regenerative Medicine Products Market Estimates and Projections by Region
    • 12.1.1 Global Regenerative Medicine Products Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Regenerative Medicine Products Revenue Forecast by Regions 2021-2026
  • 12.2 North America Regenerative Medicine Products Market Size Forecast (2021-2026)
    • 12.2.1 North America: Regenerative Medicine Products Sales Forecast (2021-2026)
    • 12.2.2 North America: Regenerative Medicine Products Revenue Forecast (2021-2026)
    • 12.2.3 North America: Regenerative Medicine Products Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Regenerative Medicine Products Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Regenerative Medicine Products Sales Forecast (2021-2026)
    • 12.3.2 Europe: Regenerative Medicine Products Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Regenerative Medicine Products Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Regenerative Medicine Products Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Regenerative Medicine Products Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Regenerative Medicine Products Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Regenerative Medicine Products Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Regenerative Medicine Products Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Regenerative Medicine Products Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Regenerative Medicine Products Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Regenerative Medicine Products Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Regenerative Medicine Products Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Regenerative Medicine Products Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Regenerative Medicine Products Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Regenerative Medicine Products Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter’s Five Forces Analysis
  • 13.5 Primary Interviews with Key Regenerative Medicine Products Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Regenerative Medicine Products Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Regenerative Medicine Products. Industry analysis & Market Report on COVID-19 Impact on Global Regenerative Medicine Products is a syndicated market report, published as COVID-19 Impact on Global Regenerative Medicine Products, Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Regenerative Medicine Products market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,900.00
    $5,850.00
    $7,800.00
    3,131.70
    4,697.55
    6,263.40
    3,646.50
    5,469.75
    7,293.00
    605,007.00
    907,510.50
    1,210,014.00
    325,065.00
    487,597.50
    650,130.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report